Study highlights the potential of psilocybin in treating obsessive-compulsive disorder

A new study highlights the potential of psilocybin, a psychedelic compound, in treating obsessive-compulsive disorder (OCD) and Tourette’s Syndrome.

Keto Diet on Par With Further Medication for Infants With Drug-Resistant Epilepsy

A ketogenic diet was similar in efficacy and tolerability to further anti-seizure medication for infants with drug-resistant epilepsy, a randomized clinical trial in the U.K.

December 15, 2023

Cybin Brings in Capital with Public Offering | Psychedelic Invest

On Monday, publicly-traded psychedelic company Cybin announced an overnight public offering, and its stock paid the price. This came as no surprise to anyone following

August 2, 2023

Wave rides new Phase 2 DMD data as it sets sights on accelerated approval

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.